p16 Promoter Hypermethylation in Human Hepatocellular Carcinoma with or without Hepatitis Virus Infection

Background: Epigenetic alteration through methylation is one of the most important steps in carcinogenesis. However, the relation between hepatitis virus infection and epigenetic alterations is poorly understood. Methods: Sixteen patients without hepatitis B virus (HBV) and hepatitis C virus (HCV) and 35 patients with HBV or HCV who underwent liver resection for hepatocellular carcinoma (HCC) were studied. Mutation of p53 was detected by direct sequencing. Methylation status of p16 was evaluated in tumor and noncancerous liver tissues by methylation-specific polymerase chain reaction. Results: In HCC without HBV and HCV, p53 mutations were detected in 5 (31%) of 16 HCCs. Methylation of p16 promoter was detected in 2 (25%) of 8 moderately differentiated HCCs, 6 (75%) of 8 poorly differentiated HCCs, and none of 16 noncancerous tissue specimens. In HCC with HBV or HCV, p53 mutations were detected in 8 (23%) of 35 HCCs. Methylation of p16 promoter was detected in 2 (100%) of 2 well-differentiated HCCs, 13 (76%) of 17 moderately differentiated HCCs, 12 (75%) of 16 poorly differentiated HCCs, and 9 (26%) of 35 noncancerous liver tissue specimens. Conclusions: Our results suggest that hepatitis viruses might induce methylation of p16 promoter in liver with chronic inflammation, before appearance of HCC.

[1]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[2]  M. Roncalli,et al.  Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma , 2002, Hepatology.

[3]  Nita Ahuja,et al.  DNA methylation and environmental exposures in human hepatocellular carcinoma. , 2002, Journal of the National Cancer Institute.

[4]  K. Jang,et al.  Cooperative repression of cyclin‐dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein , 2002, FEBS letters.

[5]  W. Yeo,et al.  Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  A. Tannapfel,et al.  INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas , 2001, Oncogene.

[7]  H. Hotta,et al.  Inhibition of p21/Waf1/Cip1/Sdi1 Expression by Hepatitis C Virus Core Protein , 2001, Microbiology and immunology.

[8]  S. Thibodeau,et al.  hMLH1 and hMSH2 expression in human hepatocellular carcinoma. , 2001, International journal of oncology.

[9]  Ding‐Shinn Chen,et al.  Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. , 2001, Gastroenterology.

[10]  R. Makino,et al.  Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  M. Toyota,et al.  Detection of hypermethylation of thep16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus , 2001, Gut.

[12]  Hiromu Suzuki,et al.  Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma , 2000, Oncogene.

[13]  Q. Tao,et al.  DNA methylation and the Epstein-Barr virus. , 1999, Seminars in cancer biology.

[14]  W. Doerfler,et al.  Insertion of Foreign DNA into an Established Mammalian Genome Can Alter the Methylation of Cellular DNA Sequences , 1999, Journal of Virology.

[15]  H. Asakura,et al.  p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma , 1999 .

[16]  W. Lau,et al.  High frequency of p16INK4A gene alterations in hepatocellular carcinoma , 1999, Oncogene.

[17]  Yoshiharu Matsuura,et al.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.

[18]  S. Hirohashi,et al.  Increased DNA Methyltransferase Expression Is Associated with an Early Stage of Human Hepatocarcinogenesis , 1997, Japanese journal of cancer research : Gann.

[19]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Sugio,et al.  The clinical significance of p53 gene mutation in hepatocellular carcinomas from japan , 1995, Hepatology.

[21]  M. Zhu,et al.  Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. , 1993, Oncogene.

[22]  S. Hirohashi,et al.  p53 gene mutation spectrum in hepatocellular carcinoma. , 1992, Cancer research.

[23]  G. Jay,et al.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.

[24]  S. Hirohashi,et al.  Gene Mutation Spectrum in Hepatocellular Carcinoma 1 , 2006 .

[25]  金戸 宏行.  Detection of hypermethylation of the p16INK4A gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus , 2001 .

[26]  松村 卓哉.  Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas , 2001 .

[27]  H. Asakura,et al.  p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. , 1999, Gastroenterology.